top
Search terms
Results 1 - 6 of 6 - ordered by :
Ehjcardiovascrec

Pharmacological inhibition of CaMKII-but not of protein kinase A-mediated PLB phosphorylation totally abolished the increased effects of β-adrenergic stimulation on cardiac contractility and ...

Cardiovascular Research, Original Article in Review Focus Series on Calmodulin and Ca, Sevdalina Yurukova, Ana Kilić, Katharina Völker, Kirsten Leineweber, Nataliya Dybkova, Lars S. Maier, ...

Date : 01/03/2007
Ehjcardiovascrec

The human receptor was selected for two reasons: (i) compared to other species, human cardiac muscle exhibits the strongest negative inotropic effect induced by β3-AR agonists [5] and, (ii) ...

Cardiovascular Research, Editorial, Enn K. Seppet

Date : 01/08/2003
Ehjcardiovascrec

The human receptor was selected for two reasons: (i) compared to other species, human cardiac muscle exhibits the strongest negative inotropic effect induced by β3-AR agonists [5] and, (ii) ...

Cardiovascular Research, Seppet, Enn K.

Date : 01/08/2003
Ehjcardiovascrec

Pharmacological inhibition of CaMKII-but not of protein kinase A-mediated PLB phosphorylation totally abolished the increased effects of β-adrenergic stimulation on cardiac contractility and ...

Cardiovascular Research, Yurukova, Sevdalina, Kilić, Ana, Völker, Katharina, Leineweber, Kirsten, Dybkova, Nataliya, Maier, Lars S., Brodde, Otto-Erich, Kuhn, Michaela

Date : 01/03/2007
Ehjcardiovascrec

Pharmacological inhibition of CaMKII-but not of protein kinase A-mediated PLB phosphorylation totally abolished the increased effects of β-adrenergic stimulation on cardiac contractility and ...

Cardiovascular Research, Yurukova, Sevdalina, Kilić, Ana, Völker, Katharina, Leineweber, Kirsten, Dybkova, Nataliya, Maier, Lars S., Brodde, Otto-Erich, Kuhn, Michaela

Date : 01/03/2007
Ehjcardiovascrec

The human receptor was selected for two reasons: (i) compared to other species, human cardiac muscle exhibits the strongest negative inotropic effect induced by β3-AR agonists [5] and, (ii) ...

Cardiovascular Research, Seppet, Enn K.

Date : 01/08/2003